{"abstract": "The congressmen\u2019s inquiry about the $84,000 price for a 12-week course of treatment spurred a sell-off in biotechnology stocks on Friday.", "web_url": "https://www.nytimes.com/2014/03/22/business/lawmakers-attack-cost-of-new-hepatitis-drug.html", "snippet": "The congressmen\u2019s inquiry about the $84,000 price for a 12-week course of treatment spurred a sell-off in biotechnology stocks on Friday.", "lead_paragraph": "A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. ", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/22/business/Biotech/Biotech-articleLarge.jpg", "height": 363, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/03/22/business/Biotech/Biotech-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 363}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/22/business/Biotech/Biotech-jumbo.jpg", "height": 620, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/22/business/Biotech/Biotech-superJumbo.jpg", "height": 1240, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/22/business/Biotech/Biotech-thumbStandard-v2.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/03/22/business/Biotech/Biotech-thumbStandard-v2.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/03/22/business/Biotech/Biotech-thumbLarge-v2.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Lawmakers Attack Cost of New Hepatitis Drug", "kicker": null, "content_kicker": null, "print_headline": "Lawmakers Attack Cost of New Hepatitis Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Sovaldi (Drug)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Pollack, Andrew", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 4, "major": "N"}, {"name": "subject", "value": "United States Politics and Government", "rank": 5, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Gilead Sciences Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "House Committee on Energy and Commerce", "rank": 8, "major": "N"}, {"name": "persons", "value": "Waxman, Henry A", "rank": 9, "major": "N"}, {"name": "persons", "value": "Pallone, Frank Jr", "rank": 10, "major": "N"}, {"name": "persons", "value": "DeGette, Diana", "rank": 11, "major": "N"}, {"name": "subject", "value": "Biotechnology", "rank": 12, "major": "N"}, {"name": "subject", "value": "Stocks and Bonds", "rank": 13, "major": "N"}], "pub_date": "2014-03-22T00:22:40+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/81ddcf7d-5890-51f4-9f49-bb0b2490dd6c", "word_count": 840, "uri": "nyt://article/81ddcf7d-5890-51f4-9f49-bb0b2490dd6c"}